Rallybio Corporation
RLYB
$0.626
$0.0325.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 154.52% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 154.52% | -- | -- | -- | -- |
| Cost of Revenue | -46.31% | -58.48% | -35.45% | 35.79% | 211.65% |
| Gross Profit | 47.79% | 60.07% | 36.95% | -33.52% | -209.38% |
| SG&A Expenses | -21.05% | -28.76% | -27.82% | -27.35% | -21.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.56% | -33.51% | -26.73% | -10.16% | -0.15% |
| Operating Income | 41.35% | 34.61% | 27.54% | 10.96% | 0.55% |
| Income Before Tax | 43.62% | 36.83% | 22.52% | 5.04% | -4.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.62% | 36.83% | 22.52% | 5.04% | -4.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.62% | 36.83% | 22.52% | 5.04% | -4.76% |
| EBIT | 41.35% | 34.61% | 27.54% | 10.96% | 0.55% |
| EBITDA | 41.39% | 34.65% | 27.57% | 10.96% | 0.53% |
| EPS Basic | 47.84% | 42.38% | 27.36% | 11.75% | 8.17% |
| Normalized Basic EPS | 45.36% | 39.77% | 31.74% | 16.23% | 12.32% |
| EPS Diluted | 47.84% | 42.38% | 27.36% | 11.75% | 8.17% |
| Normalized Diluted EPS | 45.36% | 39.77% | 31.74% | 16.23% | 12.32% |
| Average Basic Shares Outstanding | 7.71% | 9.76% | 7.65% | 8.60% | 13.05% |
| Average Diluted Shares Outstanding | 7.71% | 9.76% | 7.65% | 8.60% | 13.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |